4.84BMarket Cap
LossP/E TTM
Oruka Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Oruka Therapeutics Inc is 8.61, ranking 80 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -40.48, which is -226.33% below the recent high of 51.13 and -1.40% above the recent low of -41.04.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.